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Abstract 
 
Within bone, mesenchymal stromal cells (MSCs) exist within the bone marrow stroma (BM-
MSC) and the endosteal niche, as cells lining compact bone (CB-MSCs).  This study isolated 
and characterised heterogeneous MSC populations from each niche and subsequently 
investigated the effects of extensive cell expansion, analysing population doublings 
(PDs)/cellular senescence, colony forming efficiencies (CFEs), MSC cell marker expression 
and osteogenic/adipogenic differentiation.  CB-MSCs and BM-MSCs demonstrated similar 
morphologies and PDs, reaching 100PDs.  Both populations exhibited consistent telomere 
lengths (12-17kb), minimal senescence and positive telomerase expression.  CB-MSCs (PD15) 
had significantly lower CFEs than PD50, unlike BM-MSCs.  CB-MSCs and BM-MSCs both 
expressed MSC (CD73/CD90/CD105), embryonic (Nanog) and osteogenic markers (Runx2, 
osteocalcin) but no hematopoietic markers (CD45).  CB-MSCs (PD15) strongly expressed 
Oct4 and p16INK4A. At early PDs, CB-MSCs possessed a strong osteogenic potency and low 
potency for adipogenesis, whilst BM-MSCs possessed greater overall bipotentiality for 
osteogenesis and adipogenesis. At PD50, CB-MSCs demonstrated reduced potency for both 
osteogenesis and adipogenesis, compared to BM-MSCs at equivalent PDs.  This study 
demonstrates similarities in proliferative and mesenchymal cell characteristics between CB-
MSCs and BM-MSCs, but contrasting multipotentiality.  Such findings support further 
comparisons of human CB-MSCs and BM-MSCs, facilitating selection of optimal MSC 
populations for regenerative medicine purposes. 
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1. Introduction 
The bone marrow cavity contains a rich source of mesenchymal stromal cells (BM-MSCs).  
These MSCs can be considered as a distinct type of stromal progenitor cells with defined 
capabilities for self-renewal and differentiation into lineages of mesenchymal origins, such as 
bone, fat and various other collagenous connective tissues [1, 2]. Consequently, BM-MSCs are 
highly considered to offer great potential for application in stem cell repair and regenerative 
therapies [3], most notably for bone itself.  They are also often used in the development of in 
vitro models of disease progression and for the monitoring of therapeutic efficiency in 
accelerating a wide variety of clinical outcomes [4-7].  
BM-MSCs have been described within two distinct niches within the bone environment, 
namely the perivascular niche organized around sinusoidal endothelial cells and the endosteal 
niche centralized around pre-osteoblasts and oseoblasts of the bone lining cells [8].  Via cell-
cell contacts, the BM-MSCs of both niches provide a role in supporting the activities of the 
hematopoietic cells, in addition to facilitating bone remodeling and repair, whether for stress-
induced microfractures or major trauma-induced fractures [8]. Furthermore, within both these 
niches, isolated MSCs represent heterogeneous populations, commonly forming the progenitor 
cells of adipocytes and osteoblasts where balanced differentiation in favour of osteogenesis is 
important for successful bone repair.  Indeed, dysregulation towards adipogenesis during bone 
remodeling has been linked to several pathologies of weakened bone seen in obesity, 
osteopeania and osteoporosis [9].  Clonal analyses of BM-MSCs have identified cell 
populations that are described as highly proliferative transit amplifying cells, capable of 
forming colonies and possessing multi-potency, alongside cell populations with lower colony 
forming efficiencies that are more restricted in their lineage potential [10, 11].    Such 
understanding has consequences for the protocols used to isolate BM-MSCs, whether for use 
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in cell-based therapies or in vitro cell models, where cell populations with defined 
characteristics are desirable. For most isolations of MSCs from tissues such as bone, the cell 
population can be regarded as heterogeneous containing “immature” highly proliferative 
multipotential cells, along with lineage committed and differentiated cells with slower 
proliferative capacity which can vary greatly between sampled individuals [3,12].    Following 
isolation, cells are invariable expanded in vitro to obtain sufficient numbers.  This can lead to 
further change in the heterogeneous profile of the MSCs, which are highly likely to impact on 
a whole range of cellular behaviour, such as multi-potency, efficacy of differentiation, 
proliferation, migration and immunosuppression [12].  However, despite the huge variations in 
isolation procedures being identified to be a major hindrance to clinical translation, very few 
studies have compared isolation techniques and the characterisation of the cell populations 
following expansion.  
Classically, MSCs were isolated from the bone marrow tissues of human and rodent species, 
by manipulating their distinct ability to expand in culture following adherence to plastic culture 
surfaces, as the techniques have shown a potential in reducing the co-culture of haematopoietic 
cells [13]. However, the property of plastic adherence itself is not sufficient for the isolation of 
MSCs due to the abundant existence of unwanted hematopoietic cells, endothelial cells and 
granulo-monocytic cells, reported in early and later stages of sub-culture. Frequently, bone 
marrow stromal cells are subjected to fractionation on a density gradient solution, such as 
FicollTM, to improve the purification strategies, followed by low density plating methods 
[14,15]. Extending from initial studies isolating stem cell populations from the epidermis [16], 
recent studies have also been successful in the isolation of heterogeneous MSC populations 
from bone marrow, dental pulp and the oral mucosa, by virtue that these adult stem cells exhibit 
high surface α5β1 integrin expression, to promote rapid adhesion to fibronectin-coated culture 
plates, providing easier selection from haematopoietic and endothelial cell types present in 
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these tissue [17-20].  With the growing development of technologies in bone engraftment and 
skeletal tissue repair, the search for potential MSC candidates with specific pro-osteoinductive 
and pro-osteoconductive capacities directly derived from endosteal niche, have been described 
as promising for application in bone repair treatments. Against this clinical aim, recent studies 
have successfully performed the isolation of MSCs from mouse compact bone explants, 
suggesting the potential application of this method as an alternative in providing MSCs for 
bone repair therapies and for in vitro models of cellular behaviour [21 - 23].   
This study presents data comparing the isolation, expansion and characterisation of 
heterogeneous rat MSCs from bone marrow and compact bone explants. Attention is given to 
compare the efficiency of each purification method by analyzing cell proliferative capacity, 
maintenance of mesenchymal stromal / stem cell characteristics and differentiation potential 
towards osteogenic and adipogenic lineages, following extensive culture in vitro. The 
successful isolation, expansion and characterisation of these MSCs revealed that both bone 
marrow and compact bone offer the potential for two contrasting in vitro cell models that differ 
with respect to their differentiation potency.  The results presented thus offer an initial 
characterisation relating to the differing heterogeneous nature of the MSC populations from 
each niche, which is valuable in considering appropriateness of the isolation and expansion 
protocols during study design and provide an initial viability assessment of the potential use of 
each stromal cell population for future stem cell therapy development.  
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2. Materials and Methods 
Bone femurs were harvested from 28 day old male Wistar rats, sacrificed in accordance with 
Code of Practice for the Humane Killing of Animals, under Schedule 1 of the Animals 
(Scientific Procedures) Act, 1986.  Prior to dissection, animals were sterilized by immersion in 
70% alcohol.  
2.1. Isolation and culture of BM-MSCs from bone marrow. Six-well plates were coated with 
1ml/well of 10μg/ml human plasma fibronectin (Sigma-Aldrich, Poole, UK), reconstituted in 
+PBS (phosphate buffered saline, supplemented with containing 1mM Ca2+ and 1mM Mg2+) 
and left for 24h at 4°C. The femur and humerus were aseptically dissected, cleaned of all 
connective tissues and collected on ice in 10ml isolation medium (IM), αMEM with 
ribonucleosides and deoxyribonuclosides (ThermoFisher Scientific, Paisley, UK), 
supplemented with 10% antibiotic-antimycotic (Sigma-Aldrich). Bone marrow cells were 
collected by flushing of each long bone with 10ml of complete culture medium (CCM), 
containing αMEM with 20% heat-inactivated Foetal Bovine Serum (FBS, ThermoFisher 
Scientific), 1% antibiotic-antimycotic and 100μm L-ascorbic acid 2-phosphate (Sigma-
Aldrich) and filtered through a 70μm nylon cell strainer into T-75 tissue culture flasks (Greiner 
Bio-One International, Kremsmünster, Austria). Cells were incubated at 37°C, 5% CO2 and 
non-adherent cells were removed by change of medium after 24h.  On day 3, cells were 
retrieved using StemPro®
 
Accutase® (ThermoFisher Scientific) and counted. To preferentially 
select immature MSCs expressing high levels of cell surface β1 integrins, cells were seeded at 
4,000 cells/cm2
 
in 1ml of serum-free CCM into each well of fibronectin-coated plates, 
immediately after removing PBS. After 20min incubation at 37°C non-adherent cells were 
removed by washing with PBS. Adherent cells were cultured in CCM at 37°C, 5% CO2. Culture 
medium was changed every 2-3 days.  
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2.2. Isolation and culture of rat bone chip explant CB-MSCs. From the long bone remnants 
recovered from above, the diaphysis were cut into 1-3mm2
 
bone chips and digested with gentle 
agitation in 3mg/ml collagenase II (Sigma-Aldrich) in αMEM for 2h at 37°C. Digestion 
medium and released cells were removed and the bone chips were washed three times with 5ml 
CCM. The digested bone chips were then incubated with CCM at 37°C, 5% CO2. On day 3, 
the bone chips and non-adherent cells were discarded by washing with PBS and remaining 
adherent cells were cultured to allow for colony formation and expansion. After 12 days, CB-
MSCs were harvested using StemPro®Accutase® (Passage 0), counted and re-seeded at 4,000 
cells/cm2
 
in T-25 culture flasks (Greiner Bio-One International). Culture medium was changed 
every 2-3 days.  
2.3. Histological examination.  During the isolation procedure tissue samples of the bone were 
taken before flushing away bone marrow tissue, and of the resultant bone chips before and after 
collagenase treatment.  Samples were demineralised in 10% formic acid, for 72h, then 
dehydrated through an ascending concentration of alcohols, which was cleared with xylene 
prior to embedding in paraffin wax.  Five μm sections were cut, mounted onto poly-L-lysine 
coated glass slides (ThermoFisher Scientific), dried overnight at 60ºC and then stained with 
Haematoxylin and Eosin.  Stained sections were mounted using DPX glue (Raymond A Lamb, 
East Sussex, UK), prior to viewing using a light microscope, with digital images captured.      
 
2.4. Assessment of population doubling levels. On reaching 70-80% confluency, cells were 
passaged and cell counts were determined.  Population doubling (PD) values were assessed as 
a proportion of the original number of cells seeded using the formula:  
log final cell number-log seeding cell number/log2 × days in culture.  
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Cumulative PD were plotted against time in culture and performed in duplicate for each 
isolation procedure. 
2.5. Cell morphological analysis. Cellular morphology was regularly examined over the entire 
culture duration by light microscopy.  In addition, cells at PD15, PD50 and PD100 were 
cultured at a density of 4000 cells / cm2 for 24h in glass chamber slides (BD Biosciences, 
Oxford, UK) before fixation with 4% (v/v) paraformaldehyde solution and permeabilisation 
with 200 μl/well 0.1% Triton-X100 (Sigma-Aldrich), for 30min. Cells were blocked with 
200μl/well 1% bovine serum albumin (BSA, ThermoFisher Scientific) in Tris Buffered Saline 
(1% BSA-TBS), for 1h at room temperature and the actin cytoskeleton stained with 20µg ml/ml 
phalloidin-FITC (Sigma-Aldrich), 1% BSA-TBS and incubated for 1h, 4°C in darkness. Cells 
on the glass slides were mounted using Vectashield®
 
mounting medium with DAPI (Vector 
Laboratories Ltd, Peterborough, UK) and images were captured using an ultraviolet (UV) 
microscope.   
2.6. Colony forming efficiency. Cells were seeded at a density of 100 cells / well of a 6-well 
plate and cultured for a period of 12 days. Visual observations were performed every 24h where 
colonies of 32 cells or more were recorded. 
2.7. SA-β-galactosidase staining for cell senescence. Cell senescence was analysed by the 
presence of senescence associated (SA)-β-galactosidase staining using a Senescence Cells 
Histochemical Staining Kit (Sigma-Aldrich), according to manufacturer’s instruction. Cell 
were viewed by light microscopy and the average percentage blue-stained positive cells 
calculated from 5 random fields of view (30μm2).  
2.8. Telomere length determination. Cells cultured at a density of 1x104 cells / cm2 to 80% 
confluence, before treatment with proteinase K and purified with DNEasy Blood and Tissue 
Kit (Qiagen, Crawley, UK). Purified DNA was run on a 0.8% (w/v) agarose gels and Southern 
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blotted onto a nylon membranes according to manufacturer’s instruction for the TeloTAGGG 
Telomere Length Assay kit (Roche, Welwyn Garden City, UK) 
2.9. Reverse transcription PCR. Total RNA was extracted using the RNeasy® Mini kit and 
QIAShredder (Qiagen Ltd., Crawley, UK).  RNA purity and quantity was determined at 
260nm/280nm absorbance. cDNA was synthesised from 500ng of total RNA using 5μl 5X  
Moloney murine leukaemia virus (M-MLV) buffer, 0.5μg Random Primers, 0.625μl RNasin, 
1.25μl deoxynucleotide triphosphates (dNTPs; 10mM) and 1μl M-MLV reverse transcriptase, 
reconstituted to 15μl with DNase-free water (all Promega, Southampton, UK, total volume 
25μl), at 37°C for 1h, followed by 95°C for 5 min. 
cDNA was synthesized from 500ng of total RNA using 1μl random primer (Promega), added 
to RNAase-free water to a final volume of 15μl. The sample was run at 70°C for 5min. RT 
reaction mix was prepared, containing 5μl 5X Moloney Murine Leukemia Virus Reverse 
Transcriptase (MMLV) reaction buffer, 3.4μl 10mM dNTPs, 0.6μl RNasin and 1μl MMLV 
reverse transcriptase, 15μl of Random Primer / RNA mix and reconstituted to 25μl with DNase-
free water (all Promega) and performed in a thermocycler at 37°C for 1h. A reaction mix minus 
mRNA was prepared as a negative control.  PCR was performed using 1μl cDNA and reaction 
reagents 5μl 5x buffer, 0.5μl 10mM dNTP, 1.25μl 10μm forward and reverse primer (as shown 
in Table 1, Primer Design Ltd., Southampton, UK), 1μl 25mM magnesium chloride, 0.25μl 
Taq polymerase, reconstituted to 25μl per reaction with RNAase-free water (Promega). β-actin 
was used as a housekeeping gene. Reactions were performed in a thermocycler, with an initial 
denaturing step of 94°C for 5min, followed by 35 cycles of 1min, 94°C denaturing step of 30s, 
55°C annealing step of 30s, 72°C extension step, with a final 72°C extension step for 7min. 
The same conditions were applied to all primers with exception for Nanog, Oct4, CD73 and 
CD105, which used an annealing temperature of 52°C; and osteocalcin using annealing 
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temperature of 62°C. Products were separated using 2% agarose gels and viewed under UV 
light. Images were captured using Quantity One Image Analysis Software (Bio-Rad, Hemel 
Hempstead, UK). 
2.10. qRT-PCR analysis. cDNA was generated as described above and diluted 1:5 with 
RNAase -free water. Each qRT-PCR reaction was performed using 2.5μl 3μm primers (forward 
and reverse, see Table 1), 5μl diluted cDNA sample and 10μl SYBR Green Precision qRT-
PCR Master Mix (Primer Design Ltd.). All samples were analysed in triplicate in Bright White 
96-well plates (Primer Design Ltd.), using an ABI Prism 7000 Sequence Detection System and 
ABI Prism 7000 SDS Software V1.0 (ThermoFisher Scientific). Reactions conditions were: 1 
cycle of 95°C for 10min, 40 cycles of 95°C for 15s, 55°C for 30s and 72°C for 30s for all 
primers except for osteocalcin, where the annealing temperature was set at 62°C. For 
quantitative analysis, the gene expression profile were normalised to expression of β-actin as 
the housekeeping gene, using the 2–ΔΔCt method (Livak and Schmittgen 2001). Gene expression 
was presented as fold increases or decreases compared gene expression in non-differentiating 
medium at day 0.  
2.11. Assessment of bi-potential differentiation. In order to assess the differentiation capacity 
of the isolated MSCs, the expression of specific differentiation markers and transcription 
factors were examined, both at gene and protein level. MSCs were examined at 15PD and 
50PDs.  
2.11.1. Osteogenic induction: MSCs were seeded at 4,000 cells/cm2 in 6-well plates for total 
RNA extraction and 8-well chamber slides for histological staining. Cells were cultured in 
CCM for 24h, which was then replaced with osteogenic mineralising medium consisting of 
αMEM with ribonucleosides and deoxyribonuclosides, supplemented with 10% FBS, 1% 
antibiotics-antimycotics, 100μm L-ascorbic acid 2-phosphate, 10nM dexamethasone and 
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100uM β-glycerophosphate (all from Sigma-Aldrich) and further incubated in 37°C, 5% CO2, 
with medium changes every 2 to 3 days. As a negative control, cells were also cultured in 
CCM. At day 28, cells were fixed for 10min with 4% paraformaldehyde and mineral calcium 
deposition was stained with 20mg/ml alizarin red S (Sigma-Aldrich), pH 4.2 for 30min, with 
images captured by light microscopy. mRNA expression of osteogenic markers, osteocalcin 
and osterix, was also examined on day 2, 7, 14 and 28 by Q-PCR, as described above.  
2.11.2. Adipogenic induction: Adipogenesis was promoted using the method previously 
reported by Davies et al., 2010.  Cells were plated at 10,000 cells/cm2 and cultured in CCM 
until 90% confluent.  Cells were then cultured in adipogenic induction medium (AIM; αMEM 
with ribonucleosides and deoxyribonuclosides, 10% FBS, 100μm L-ascorbic acid 2-phosphate, 
1μM dexamethasone, 100μM indomethacin, 100μM 3-isobutyl-1-methylxanthine, 1% 
antibiotics-antimycotics (all from Sigma-Aldrich), 37°C, 5% CO2 for 6 days, with media 
changed every 72h.  Cells were then cultured for 48h in adipogenic maintenance medium 
(AMM; αMEM with ribonucleosides and deoxyribonuclosides, supplemented with 10% FBS, 
100μm L-ascorbic acid 2-phosphate, 10μg/ml insulin, 1% antibiotics-antimycotics) and then 
cultured again until day 14 in AIM.  As a negative control, cells were cultured for 14 days in 
CCM, as described above.  Intracellular lipid-rich vacuole accumulation was visualised by Oil 
Red O staining (500µl / well, Sigma-Aldrich; 3.5g/l in isopropanol, mixed 3:2 with double-
distilled water), for 10min or the fluorescent histological stain LipidTOXTM (ThermoFisher 
Scientific) following the manufacturer’s protocol. Digital images were captured using either a 
light or a fluorescence microscope respectively.  mRNA samples were collected on days 2, 7 
and 14 and gene expression for adipogenic markers, adiponectin, PPARγ, lipoprotein lipase, 
C/EBPα, examined by RT-PCR and Q-PCR as described above. 
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2.12. Statistical analysis. Data were expressed as mean ± standard error of mean (SE). Data 
were statistically compared using Analysis of Variance (ANOVA), with a Tukey's post-hoc 
test, using SPSS version 20.0 (IBM, New York, USA), with a significance level accepted at 
p<0.05.  
 
 
 
3. Results 
3.1. Histological analysis of isolation procedure.  Tissue samples were processed for 
Haematoxylin and Eosin staining to demonstrate cells present before flushing away of the bone 
marrow, after flushing away of the bone marrow, and after treatment with the collagenase.  The 
results indicate the range of cells present in the central bone marrow cavity (Figure 1 A), the 
majority of which are readily flushed away with the exception of a few remnant cells lining the 
endosteal surface of the bone (Figure 1B).  Bone within the femoral shaft consisted of cortical 
lamellar bone, with a strong network of Haversian and Volkmann canals that were lined with 
perivascular associated cells (Figure 1C).  Treatment of this osseous tissue with the relatively 
high concentration of collagenase lead to some loss of the mineralised tissues, releasing cells, 
including perivascular MSCs and progenitor osteoblasts lining the surfaces of the Haversian 
and Volkmann canals (Figure 1 D). 
  
3.2. Examination of stromal cell characteristics. The effects of different separation methods 
and niche source on the proliferative lifespan for each isolated CB-MSCs and BM-MSCs, as 
determined through the cumulative population doublings (PDs), are shown in Figure 2A. 
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Cumulative PD profiles were repeated on two different occasions and demonstrate a consistent 
proliferation pattern with little variation between CB-MSCs and BM-MSCs.  Both populations 
demonstrated an initial lag phase over 60 days, followed by a rapid exponential growth 
reaching PD100.  Both MSC populations rapidly generated a confluent monolayer from PD15, 
reaching 70%-80% confluence every 2-3 days, with the average PDs recorded per week was 
5.4 for CB-MSCs and 5.2 for BM-MSCs respectively.  
Cells from CB-MSCs and BM-MSCs, at PD 15, PD50 and PD100, positively expressed the 
mesenchymal progenitor cells surface antigens, CD73 (ecto-5-nucleotidase), CD90 (Thy-1) 
and CD105 (endoglin) and were found to be negative for the expression of CD45 
(hematopoietic surface antigens) (Figure 1B).  CB-MSCs at PD15 expressed CD34, which was 
lost by PD50 and absent in all BM-MSC populations. Both MSC populations maintained 
expression of the embryonic stem cell marker, Nanog, while Oct4 was only highly expressed 
in CB-MSCs at PD15 with faint expression at PD50 and PD100.  Oct4 was absent from BM-
MSCs. The expression of adipogenic differentiation marker, PPARγ and chondrogenic marker 
Sox9 were negative in MSCs from both groups. Analyses also demonstrated positive 
expression of Runx2, along with a detectable low expression of osteocalcin in CB-MSCs and 
BM-MSCs at all PDs examined.  
Figure 2C shows the CFEs for CB-MSC or BM-MSC populations at PD15 and PD50.  The 
results indicate that CB-MSCs at PD15 have a significantly lower CFE, compared with cells at 
PD50 (p<0.001 at days 3-6) and BM-MSCs at either PD15 or PD50.  The CFE of BM-MSCs 
was observed to decrease as cumulative PDs increased from PD15 to PD50. 
 
3.3. Characterisation of cell morphology and absence of cell aging. Images presented in 
Figure 3 show the morphologies of cells in each MSC population at both high magnification 
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with actin staining.  Images indicate that MSCs taken from PD15, revealed clear observation 
of large stellate-shaped cells, with flattened and nucleated spread body, mixed with smaller 
amount of spindle-shaped, fibroblastic-like morphology cells. However, at PD50, the smaller 
cells with a more fibroblastic-like appearances were the predominant cell type present, with an 
organised pattern of actin cytoskeleton, formed centrally within a spindle-shaped cells in the 
culture.  At PD100, both CB-MSCs and BM-MSCs populations demonstrated the presence of 
small stellate-like with short processes.  
During this extended culture, CB-MSCs or BM-MSCs showed little signs of cellular 
senescence (Figure 4).  Analysis of telomere lengths indicated little shortening during extended 
culture (Figure 4A), which correlated with the continued expression of rTERT (Figure 4C). 
BM-MSCs had slightly longer telomere lengths, ranging from approximately 25.6 to 6.3kbp, 
compared to CB-MSCs which ranged from 23.4 to 3.1kbp, but these represent average values 
from 3 separate blots and were deemed to be statistically non-significant.  Further analyses 
indicated that cells were non-senescent, which was confirmed by <2% of cells per 30μm2  
staining positive for SA-β-galactosidase (Figure 4D) and cells still being able to achieve a 
doubling rate >4.9 PD/week (Figure 2A).   
Analysis of genes associated with cell cycle regulation (Figure 4D) showed that all cell 
populations expressed the tumour suppressor gene, p53 and downstream gene, p21Waf1 
(regulator of cell cycle progression at G1 and S phase). However, another recognized tumour 
suppressor gene, p16INK4A, was only expressed in CB-MSCs at PD15, which was lost by PD50.   
 
3.3. Osteogenic and adipogenic differentiation of MSCs.  At PD50, following 28 days culture 
in osteogenic medium, both MSCs populations demonstrated distinct formation of mineralised 
bone nodules that stained positive with Alizarin red (Figure 5C-D). Staining was greater in 
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BM-MSCs.  These results were confirmed by the analysis of gene expression for osteoblast-
specific markers, osterix and osteocalcin (OCN) by qPCR (Figure 5E; presented as fold-
differences compared to before and after treatment with the inductive medium).  Analyses 
indicated that in the presence of osteoinductive media, both CB-MSC and BM-MSCs showed 
considerable fold-change increases in these osteogenic genes during induction, with a 
significantly greater fold increase observed in BM-MSCs noted at days 7 and 21 (p<0.01). CB-
MSCs indicated higher fold-change increases in osterix at day 2, but this high expression was 
not sustained as cultures continued in osteoinductive media.  
Adipogenic differentiation was also successfully induced in both CB-MSC and BM-MSCs, 
with Oil Red O staining indicating the formation of larger and clearer lipid droplets in the 
differentiated BM-MSCs (Figure 6A-B).  These observations correlated with the higher gene 
expression of lipoprotein lipase in BM-MSCs, with roles proposed to be involved in fatty acid 
uptake and storage (Figure 6C).  However, qPCR also demonstrated the earlier induction of 
adipogenic master gene, C/EBP4 and downstream gene, FABP4, within the CB-MSC cell 
population (Figure 6C).   The adipogenic and osteogenic potency of CB-MSC at PD15 and 
PD50 wre also examined using staining techniques for mineral deposition using Alizarin Red 
and formation of lipid droplets using the fluorescent dye, LipidTOXTM (Figure 7).  At PD50, 
CB-MSCs demonstrated an increased potential for adipogenic induction and a reduced 
potential for osteogenic induction, compared with CB-MSCs at PD15. 
 
 
 
 
 
16 
 
4. Discussion 
The present study presents an original comparative analysis pertaining to the isolation, 
expansion and characterisation of heterogeneous MSC populations potentially derived from 
the cell niches associated with bone marrow stroma (achieved via preferential fibronectin 
adherence plating techniques; BM-MSCs), and with the endosteal surface of rat bone chip 
explants (CB-MSCs).  Regardless of cell origin and isolation technique, all purified MSC 
populations were found to be positive for selected MSCs markers, CD105, CD90 and CD73, 
indicating that they were of mesenchyme origin and meeting the suggested requirements of the 
International Society of Cell Therapy (ISCT) position statement [13].  These populations were 
negative for CD45, indicating that the isolated population was successfully separated from 
heamatopoietic stem cells that are present in high numbers in the bone marrow stroma and 
associated with the endosteal niche [8] which would interfere with a full characterisation of 
MSCs. Both isolation techniques were successful in the isolation of multi-potent MSCs which 
were capable of sustaining long-term in vitro expansion up to PD100.  Analysis of cells at 
PD50 indicated that both populations maintained MSCs that were bi-potential for osteoblastic 
and adipogenic lineage differentiation.  For both CB-MSC and BM-MSC cell populations, cell 
doubling only significantly increased when the cells had achieved approximately PD10.  
Similar lag periods in high proliferative activity have been reported previously [20] and 
possibly reflects the expected low numbers of highly proliferative MSCs expected in these 
isolations, which subsequently expand to become established within the heterogeneous MSC 
population, and / or cells adapting to new culture conditions which differ to the in vivo niche 
environment.  For this reason, all analyses were performed when cells were rapidly 
proliferating at PD15 and beyond – a time period when cells are also more likely to be utilized 
for in vitro assay model systems or cell therapies. 
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Within this study, cells at PD15 for both CB-MSC and BM-MSC demonstrated a 
heterogeneous morphology with both small, elongated and bipolar cells and larger polygonal 
cells present.  This is consistent with previous studies examining stromal cells precursors 
isolated from bone marrow, which have continued to identify that the smaller fibroblastic-like 
cells of 60-100 µm are also actively proliferating whilst the larger polygonal cells proliferate 
more slowly [12].    Of note the larger cells appear to be lost by PD50, which may be due to 
their slower proliferation rate compared with the smaller cells faster dividing cells which thus 
dominate the culture.  The smaller cells may thus represent cells which conform to transit 
amplifying cells with greater multipotentiality, whist the larger cells may represent either more 
differentiated, lineage committed cells or larger aging, senescent cells.  The latter is the less 
likely scenario since telomere lengths remained consistently long and unchanged during culture 
expansion (25-8kbp), an observation supported by the detection of high levels of rTERT 
expression.  Further analysis of cells at PD50 indicated few senescent cells staining positive 
for SA -galactosidase, suggesting these cells may be present albeit in low numbers, although 
more analysis may be necessary to verify this conclusion.   The presence of pre-osteoblastic 
stromal cells along with nestin-positive MSC have been described within two important niches 
within the bone marrow stroma, namely the perivascular niche and the endosteal niche, where 
they are important in supporting heamatopoietic stem cells in addition to providing an 
important contribution bone remodeling and repair activities [8]. Their presence thus 
contributes to the heterogeneous nature of mesenchymal stem cells, which are evident in either 
isolations from bone marrow (BM-MSCs) or as a result of explants following collagenase 
digestion that remove all but cells associated with the endosteal niche (CM-MSCs).  CM-MSCs 
are likely to additionally contain perivascular MSCs, pre-osteoblasts and bone lining cells that 
also reside within the Haversian and Volkmann canal system, which takes a vascular supply 
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from the periosteum into the bone, in addition to supporting the osteocyte network and 
physiological bone remodeling.    
Both BM-MSC and CB-MSC populations demonstrated a consistent expression of the 
embryonic stem cell marker, Nanog, at all stages of culture.  Nanog has been proposed a role 
in supporting the proliferation of adult MSCs in the transition from in vivo quiescence to 
adaption expansive growth in vitro [24, 25]. However, within this study, we also identified 
MSC populations within CB-MSCs PD15 cell population that were CD34+ and Oct4+.  A 
CD34+ MSCs sub-population has been described within bone marrow, proposed to be 
intimately associated with the vasculature [26], and thus may relate to a quiescent arterial niche 
recently described to be present in the endosteal region [27, 28].  Expression of CD34 appears 
to be influenced by the surrounding environment and it has been documented that MSC 
expression of CD34 can change from positive to negative and vice versa, which may account 
for the loss of expression in the CB-MSC cultures beyond PD15 [25].  Oct4 has proposed roles 
in maintaining pluripotency and is used in the generation of induced pluripotent cells from 
adult MSCs [24, 29] and, of note to this present study, “induced MSCs” from CD34+ cells 
isolated from adult peripheral blood [30]. Collectively, the identification of these MSC 
markers, Nanog, CD34 and Oct4 within our CB-MSC populations would suggest the presence 
of an immature MSC sub-population maintained in an undifferentiated state, capable of 
propagation for multiple passages at least to beyond PD15, which is not identifiable in MSC 
populations derived from the bone marrow stroma.  
Irrespective of PDs, all isolated CB-MSCs and BM-MSCs in the present study showed positive 
expression of Runx2 during expansion culture in basal medium.  Although its role has not been 
fully delineated, Runx2 and osterix are required as essential to promote osteoblast 
differentiation at an early stage of induction, but inhibited terminal osteoblast differentiation 
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[31].  Runx2, with Sox5, Sox6 and Sox9, are essential for the terminal differentiation of 
chondrocytes [31].  Within the study presented herein, we failed to detect Sox9 and detected 
low levels of osterix, suggesting that both the CB-MSC and BM-MSC heterogeneous 
populations also contained osteoprogenitor and pre-osteoblasts, cells which studies have shown 
are still capable of extensive replication [32].  This commitment to the osteoblast lineage, 
however, is not expected to negate a contribution to the bi-potentiality seen with both cell 
populations.  Studies have indicated that the transcription factor, PPARɣ, can induce the 
transdifferentiation of Runx2 expressing osteoblastic MC3T3-E1 cells into mature adipocytes 
[33].  
Within their respective heterogeneous populations, both CB-MSC and BM-MSC populations 
demonstrated similar population doubling profiles, achieving between 4-5 PDs per week.  
Within each MSC population, the expression of the cell cycling genes regulating replicative 
capacity were also examined.  p21waf1/CIP1 and p53 can act in dependent and interdependent 
ways to arrest cell cycle progression at G1 and S phase, acting as tumor suppressors to regulate 
cell proliferation to rates that provide genomic fidelity during MSC division [34].  p53 is also 
a negative regulator in the formation of pre-osteoblasts and pre-adipocytes [35] and loss of p53 
leads to osteosarcoma development [36].  The expression of p21waf1/CIP1 and p53, therefore, 
regulate the steady expansion of MSCs in an undifferentiated state, and their presence in both 
populations suggest the presence of such MSC populations.  In addition, CB-MSCs at PD15 
demonstrated the additional presence of p16INK4A, which also has a proposed role in reducing 
stem cell proliferation [37, 38].  It has also been suggested as a key marker of stromal cell and 
somatic cell senescence [39], and may indicate the isolation of a senescent cell sub-populations 
within CB-MSC isolates, although telomere measurements suggested little reduction in 
lengths.  It is noteworthy, however, that protein expression of p16INK4A and p21waf1/CIP1 have 
both been detected in fully differentiated osteoblasts derived from MC3T3 cells and calvarial 
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explants, where it has been proposed that they are involved in cell growth arrest in this scenario 
[40].  It is thus tempting to speculate that the presence of p16INK4A within the CB-MSC 
population at PD15 represents a sub-population of post-mitotic differentiated osteoblast cells, 
possibly derived from the bone lining cells within the endosteal environment.  To test this 
hypothesis, we examined the ability of cells within the respective populations to form colonies 
from a single cell, correlated to their bi-potential potency.  The present study clearly 
demonstrated that CFEs for the CB-MSC population at PD15 were significantly lower 
compared to CFEs for CB-MSCs at PD 50 and BM-MSCs at either PD15 or PD50.  However, 
the CB-MSC population at PD15 demonstrated increased staining for the deposition of mineral 
containing bone nodules and reduced potential to form adipocytes, when compared to CB-
MSCs at PD50; thus supporting the presence of more mature osteoblasts in the heterogeneous 
population at PD15 of the CB-MSC population, which are subsequently lost by PD50.   
In the present study, we compared CFEs and bi-potentiality to form osteoblasts and adipocytes 
by CB-MSC and BM-MSCs at PD50, a time when the both cell populations showed similar 
gene expression profiles for MSC markers, CD73, CD90 and CD105, Nanog, the osteogenic 
marker Runx2 and cell cycle proteins, p21waf1/CIP1, p53 (CD34, Oct4 and p16INK4A positivity 
was not detected).  At this time-point, BM-MSCs had a greater potential for adipogenic and 
osteogenic differentiation, compared to CB-MSCs.  Both populations demonstrated a marked 
ability to form clonal colonies.  These results would suggest that the bone marrow population 
contained greater numbers of committed pre-osteoblasts, which are still capable, under the 
correct signalling environment, to form adipocytes [33,41].  In contrast, considering CB-MSCs 
at PD50, a more immature MSC population now predominated.  As these CB-MSC cultures 
were continued under osteogenic conditions, increased deposition of mineralizing bone 
nodules were observed, suggesting the presence of cells with osteogenic potential, which took 
longer to achieve a fully differentiated osteoblast capable of synthesizing mature bone.   
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5. Conclusion 
The study has compared two isolation techniques which have yielded two heterogeneous MSC 
populations whose characteristics vary according to the niche source of the cells. The value of 
the data is twofold.  The study offers data to provide an informed consideration for which 
isolation technique to use in selecting an in vitro model.  The protocols have been successful 
in isolating MSCs from the compact bone niche, a MSC population that is more lineage 
restricted for osteogenesis.  Such cells may be proposed to be the first responders during 
mineralized tissue repair, with the immature MSCs subsequently proliferating to replace the 
former cell population [42].  Thus, isolation of primary cells from bone explants offers MSCs 
which may be more appropriate when wishing to assess the efficacy of osteogenic therapeutics, 
where data obtained may be more relevant for the study of bone repair processes. Conversely, 
BM-MSCs may be more appropriate when assessments of tri-potentiality is required and could 
find relevance in the study of a range of tissue engineering applications outside bone 
regeneration.  In addition, the data provides an important initial characterisation to justify 
studies that further characterise the MSC populations within human models.  It is of note that 
the gold standard for bone regeneration are autologous bone grafts that contains an endosteal 
niche and hence a potential benefit from a MSC population that is lineage-restricted in terms 
of osteogenic differentiation.  Further investigation of these lineage-restricted MSCs may thus 
be of benefit in providing a more defined cell populations for stem cell based therapies.  
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Figure 1:  Haematoxylin and Eosin staining of bone samples taken during isolation of cells 
from the long bones of rats. (A) Section through the femoral shaft prior to flushing of bone 
marrow demonstrated a large network of the Haversian and Volkmann canal system within the 
cortical lamellar bone.  (B) Following removal of bone marrow, some cells lining the endosteal 
surface remain. (C) Cells are evident within the Haversian / Volkmann canal system associated 
with the perivascular system contained within.  (D) Subsequent digestion of these bone chips 
with a relatively high concentration of collagenase leads to some loss of mineralised bone, 
opening up the canal system and associated lining cells.   
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Figure 2: Analysis of MSC characteristics for cells isolated from compact bone and bone marrow stroma.  (A) Cumulative population doubling (PDs) of 
CB-MSC and BM-MSC isolates, performed on two separate occasions, demonstrated high ability for self-replication after PD10, approximately 60 days 
in culture. (B) Both CB-MSCs and BM-MSCs expressed classical MSC markers, in addition to certain of the embryonic markers.  Osteogenic marker, 
Runx2, was strongly expressed by both cell populations at all PDs examined, but were negative for chondrogenic marker, Sox9 and adipogenic marker, 
PPARɣ.  CB-MSCs demonstrated the additional presence of Oct4 and CD34.  (C) Colony forming efficiency (CFEs) demonstrated lower efficiency for 
CB-MSC at PD15 compared to BM-MSC at PD15 and PD50.  Statistically significant differences between respective populations is shown *** p<0.001, 
**p<0.01.  
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Figure 3: Cell morphology of CB-MSCs and BM-MSCs at PD15, PD50 and PD100, visualized 
following staining of cytoskeletal actin with phalloidin-FITC.  At later PDs, cells were predominantly 
observed to adopt a more elongated fibroblastic appearance, whilst at PD15, stellate cells with 
increased number of cellular processes were observed. 
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Figure 4:  Effect of continuous cell expansion on (A) Telomere length analysis for CB-MSC and BM-
MSC populations at cited PDs, by Southern blotting.  Average telomere lengths were calculated from 
3 blots and averages and range of TRF values obtained are indicated in the associated table.  Right 
hand lane represents the separated DIG-labelled telomere length standard.  (B) Expression of 
telomerase catalytic subunit, rTERT, was assessed by RT-PCR.  Continued expression of rTERT at 
PD100 is consistent with minimal change in telomere length following expanded culture.  (C) 
Staining of cell populations at PD100 with SA-β-galactosidase indicated the absence of senescent 
cells.  (D) mRNA expression of cell cycle proteins regulating arrest in cell proliferation as CM-MSCs 
and BM-MSCs as assessed by RT-PCR.  p16INK4A was only detected in CB-MSCs at PD15 and was 
lost with subsequent culture.  Continued expression of p21Waf1 and p53 were observed.   
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Figure 5: Osteogenic differentiation of CB-MSCs and BM-MSCs at PD50.  Cells were cultured 
for 28 days in the absence (A and B) or presence (C and D) of osteoinductive media and mineral 
deposition visualised by Alizarin Red staining. At PD50, osteogenic potency was observed to 
be higher for BM-MSCs, a result which is supported by (E) gene expression profiles for 
osteogenic markers by CB-MSCs and BM-MSCs. Values were normalised against the 
expression of β-actin and presented as the fold increase compared to expression value obtained 
for the respective cell population in non-differentiating media, at day 0. Each bar represent 
mean fold change ± SD, n=3 and *p<0.05, **p<0.01.  
  
32 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Adipogenic induction of CB-MSCs and BM-MSCs at PD50.  (A) CB-MSCs 
and (B) BM-MSCs were cultured in adipogenic medium for 14 days and stained with 
Oil Red O to detect neutral lipid droplet formation within the cultured cells. Potency 
was greater for BM-MSCs with results correlating with (C) gene expression of 
adipogenic markers in MSCs at PD50 quantified by qPCR. Values were normalised to 
the expression of β-actin and expression following 14 days in adipogenic media is 
presented as a fold increase or decrease compared to levels in cells cultured in basal 
media. Each bar represent mean fold change ± SD. n=3 and *p<0.05, **p<0.01.  
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Figure 7: Comparison of CB-MSCs at PD15 and PD50 for adipogenic and osteogenic 
induction.  Cells at PD15 demonstrated a greater potency for osteogenic induction and 
reduced adipogenic induction compared to cells cultured to PD50. 
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Table 1: Primers sequences for RT-PCR and qPCR analysis.   
Gene Primer Sequence Length bp Application 
CD73 F:5' TCCCGCGGCTGCTACGGCACCCAAGTG -3' 
R: 5'- ACCTTGGTGAAGAGCCGGGCCACGCCG -3' 
204 RT-PCR 
CD90 F:5'- CCTGACCCGAGAGAAGAA -3' 
R:5'- TGAAGTTGGCTAGAGTAAGGA -3' 
125 RT-PCR 
CD105 F:5'- ACATGGTGCCCACACCCGCAGCTGGCA -3' 
R: 5'- CACTGCCACCACGGGCTCCCGCTTGCT -3' 
263 RT-PCR 
CD45 F:5'- AGCAATACCAGTTCCTCTATGA -3' 
R:5'- TCCGTCCACTTCGTTATGA -3' 
113 RT-PCR 
CD34 F:5'- GTCACACTGCCTACTACTTC -3' 
R:5'- TCCTCGGATTCCTGAACAT -3' 
210 RT-PCR 
Nanog F:5'- GGGGATTCCTCGCCGATGCCTGCCGTT -3' 
R:5'- GGGATACTCCACCGGCGCTGAGCCCTT -3' 
477 RT-PCR 
Oct4 F:5'- GCCCACCTTCCCCA TGGCTGGACACCT -3' 
R:5'- GCAGGGCCTCGAAGCGGCAGA TGGTTG -3' 
563 RT-PCR 
Runx2 F:5'- CCAGATGGGACTGTGGTTACC -3' 
R:5'- ACTTGGTGCAGAGTTCAGGG -3' 
381 RT-PCR 
OCN F:5'- ACAGACAAGTCCCACACAGCAACT -3' 
R:5'- CCTGCTTGGACA TGAAGGCTTTGT -3' 
161 RT-PCR 
PPARɣ F:5'- GGAAAGACAACAGACAAA TCAC -3' 
R:5'- GAACTTCACAGCAAACTCAAAC -3' 
408 RT-PCR 
Sox 9  F:5'- CCCTTCAACCTCCCACACTACAGC -3' 
R:5'- TGTGTAGACGGGTTGTTCCCAGTG -3' 
249 RT-PCR 
rTERT F:5'- GACATGGAGAACAAGCTGTTTGC -3' 
R:5'- ACAGGGAAGTTCACCACTGTC -3' 
185 RT-PCR 
p53 F:5'- ACAGCGTGGTGGTACCGTAT -3' 
R:5'- GGAGCTGTTGCACATGTACT -3' 
83 RT-PCR 
p21waf1 F:5'- TCTTGCACTCTGGTGTCTCA -3' 
R:5'- GGGCTTTCTCTTGCAGAA -3' 
147 RT-PCR 
p16INK4A F:5'- TGCAGATAGACTAGCCAGGGC -3' 
R:5'- CTCGCAGTTCGAATCTGCAC -3' 
184 RT-PCR 
β-actin F:5'- TGAAGATCAAGATCATTGCTCCTCC -3' 
R:5'- CTAGAAGCATTTGCGGTGGACGATG -3' 
155 RT-PCR 
OSX F:5'- GCTTTTCTGTGGCAAGAGGTTC -3' 
R: 5'- CTGATGTTTGCTCAAGTGGTCG -3' 
200 qPCR 
OCN F:5'- ACAGACAAGTCCCACACAGCAACT -3' 
R:5'- CCTGCTTGGACATGAAGGCTTTGT -3' 
161 qPCR 
FABP4  F:5'- GGAATTCGATGAAATCACCCC -3' 
R: 5'- TGGTCGACTTTCCATCCCACT -3' 
104 qPCR 
C/EBPα F:5'- GGGAGAACTCTAACTCCCCCAT -3' 
R:5'- CTCTGGAGGTGGCTGCTCATC -3' 
82 qPCR 
LPL F:5'- AGGTCAGAGCCAAGAGAAGCA -3' 
R:5'- GGAGTAGGTTTTATTTGTGGCG -3' 
215 qPCR 
β-actin F:5'- GGGTCGAGTCCGCGTCCAC -3' 
R:5'- CGACGAGCGCAGCGATATC -3' 
108 qPCR 
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